Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:April 28,
As filed with the Securities and Exchange Commission on April 15, 2020 Registration No. 333 ...
EDISON EQUITY RESEARCH: ANGLE: ADR UPDATE - THIRD CLINICAL APPLICATION EMERGESAngle has announced results from a metastatic breast cancer...
EDISON EQUITY RESEARCH: ANGLE - CELLS FOR PRECISION MEDICINEAngle has transformed into a pure-play diagnostics business. Parsortix, its...
ANGLE plc's Parsortix System Harvests CTCS In 100% Of Prostate Cancer Patients Barts study demonstrates Parsortix harvested cells are clinically...
ANGLE plc appoints Jim Reuben Scientific Adviser PR Newswire GUILDFORD, England, June 3, 2015 GUILDFORD, England, June 3, 2015 /PRNewswire/...
ANGLE plc Updates Results on Ovarian Cancer Study PR Newswire GUILDFORD, United Kingdom, April 21, 2015 GUILDFORD, United Kingdom, April 21, 2015...
Results From The Sidney Kimmel Cancer Center At Thomas Jefferson University PR Newswire GUILDFORD, England, April 20, 2015 GUILDFORD, England...
S&P Capital IQ Initiates Coverage on ANGLE Plc in S&P Capital IQ Factual Stock Reports PR Newswire NEW YORK, March 16, 2015 NEW YORK...
ANGLE plc ("Angle" or "the Company") Collaboration With MD Anderson Cancer Center On Colorectal Cancer PR Newswire GUILDFORD...
ANGLE plc ("the Company") Patient Data Shows "Unprecedented Sensitivity And Specificity" For Parsortix Ovarian Cancer...
ANGLE plc ("ANGLE" Or "The Company") Corporate Collaboration With Large Pharmaceutical Company PR Newswire GUILDFORD, United...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관